Open your next pay stub and look at the health insurance line. If your employer sponsors a family plan, there is a good chance that deduction grew by about $617 over the past year. Not because the plan improved. Because premiums for job-based coverage climbed 6% to 7% between 2023 and 2024, roughly double the 3% pace of consumer-price inflation during the same stretch, according to federal survey data. For households already stretched by higher grocery bills, rent, and childcare, that gap is quietly swallowing whatever ground recent raises were supposed to recover.
Where the numbers come from
The figures are drawn from the Medical Expenditure Panel Survey, Insurance Component (MEPS-IC), a long-running statistical series produced by the Agency for Healthcare Research and Quality. Unlike private consulting surveys or broker projections, MEPS-IC samples thousands of private-sector employers using consistent methodology year over year, making its trend lines among the most reliable available.
The 2024 release tracks single, employee-plus-one, and family coverage tiers. For family plans, the increase in the employee’s share of the premium averaged $617 annually. That is roughly $24 more per biweekly paycheck, enough to erase a modest raise for many workers. Bureau of Labor Statistics data show wages grew about 4% over the same period, meaning a meaningful portion of any pay bump went to the insurer before it reached a checking account.
The findings track closely with the Kaiser Family Foundation’s 2024 Employer Health Benefits Survey, which independently reported a 7% jump in family premiums. When two major surveys built on different samples land on nearly identical numbers, the trend is hard to dismiss.
Why premiums are climbing this fast
The MEPS-IC data capture the price increase but do not explain what is driving it. Health economists point to several forces converging at once.
Hospital consolidation continues to hand large health systems leverage to negotiate higher reimbursement rates from insurers, and those costs flow directly into premiums. Surging demand for GLP-1 medications like Ozempic and Wegovy has added billions in pharmacy spending that plans did not anticipate even two years ago; Morgan Stanley estimated U.S. GLP-1 spending exceeded $24 billion in 2024. Meanwhile, utilization of routine and elective care, suppressed during the early pandemic years, has rebounded sharply, pushing claims volume higher across nearly every service category.
None of these pressures shows signs of easing as of April 2026. Mercer’s annual benefits survey projected employers should expect another 5.8% to 8% premium increase in the next renewal cycle, though those forecasts carry wide uncertainty.
What the averages hide
National figures smooth over significant variation. The 2024 MEPS-IC release does not yet include granular breakdowns by industry or region, so whether a warehouse worker in Ohio and a software engineer in Seattle absorbed the same hit remains unclear.
There is also limited visibility into how individual employers are responding. Reporting from business outlets suggests some mid-sized firms are steering workers toward high-deductible plans, raising out-of-pocket maximums, or trimming coverage for brand-name drugs and out-of-network visits. Because the federal data track premiums and contributions rather than plan design, the prevalence of those cost-shifting strategies is difficult to measure.
No federal policy response tied specifically to the 2024 MEPS-IC findings has been announced as of late April 2026. Some health-policy analysts have floated ideas ranging from tighter oversight of employer plans to expanded Affordable Care Act marketplace subsidies for workers who lack affordable job-based options, but nothing concrete has advanced.
How to protect yourself before the next open enrollment
A 6% to 7% national average does not guarantee any single household will see that exact increase. Some employers absorb more of the cost; others pass a larger share along or restructure benefits in ways that are easy to miss: a slightly higher deductible, a narrower pharmacy formulary, a new prior-authorization requirement for specialty drugs.
Workers approaching open enrollment later this year should compare total annual costs, not just the per-paycheck premium but deductibles, copays, coinsurance rates, and out-of-pocket maximums combined. Asking a benefits or HR representative to walk through year-over-year changes in writing can surface shifts that a glossy enrollment guide might skip. And for workers whose employer plan costs more than 9.02% of household income (the 2024 ACA affordability threshold), marketplace coverage with premium tax credits may be worth exploring.
When premiums are rising at twice the rate of inflation, the fine print is no longer optional reading.
